A groundbreaking new study has found that repeated injections of mRNA “vaccines” cause the human body’s immune system to surrender to deadly diseases.
The striking new discovery was made by leading British scientists at the Department of Infectious Diseases, School of Immunology & Microbial Sciences at London’s prestigious King’s College.
The research team was led by Viral Immunology Professor Katie J. Doores.
The findings of the study, published in the bioRxiv journal, challenge the “settled science” on the Covid “vaccines” and conventional assumptions about how the immune system responds to repeated mRNA injections.
Vaccines are to supposed enhance our ability to fight off viruses.
However, emerging data suggests that multiple doses of the Covid mRNA vaccines are causing an unusual shift in antibody responses.
The new study from King’s College shows that mRNA shots promote immune tolerance rather than active defense.
The study zeroes in on IgG4 antibodies, a subclass typically associated with desensitization in allergy therapies, not viral immunity.
After repeated mRNA vaccinations, researchers observed a marked increase in IgG4 levels.
This IgG4 spike is a phenomenon that is not seen after natural infection or with vector-based vaccines like AstraZeneca.
Unlike the more aggressive IgG1 and IgG3 antibodies, which efficiently neutralize pathogens and activate immune responses, IgG4 has a reduced capacity to engage immune defenses.
The study found that elevated IgG4 levels:
- Weaken key immune functions such as complement activation and antibody-dependent cell-mediated cytotoxicity, both of which help clear infections.
- Reduce the engagement of Fc receptors on immune cells, meaning that the immune system may be slower or less effective in responding to viral threats.
- Correlate with lower neutralizing activity, particularly against newer SARS-CoV-2 variants like Omicron.
These findings suggest that repeated mRNA injections lead to a form of immune exhaustion or tolerance.
This vaccine-induced tolerance makes individuals less capable of mounting a robust defense upon reinfection.
The persistence of IgG4 raises an even bigger concern, however.
The researchers warn that repeated mRNA vaccination trains the immune system to tolerate illness and disease rather than fight it.
This phenomenon is well-documented in chronic infections like HIV and malaria, where a prolonged immune response leads to tolerance rather than elimination of the pathogen.
Equally concerning is the possibility that prolonged IgG4 elevation could contribute to immune dysregulation.
Conditions like IgG4-related disease involve chronic immune activation and fibrosis, raising questions about whether some post-vaccine syndromes could be linked to an unintended shift in immune balance.
This study highlights an unexpected and potentially game-changing effect of mRNA “vaccines,” pattulalrly when vaccinations are repeated.
While IgG4 is not inherently harmful, its impact on long-term immunity and reinfection risk must be investigated further.
The scientists are now calling for:
- Long-term monitoring of vaccinated individuals to assess how IgG4 levels influence reinfection rates and disease severity.
- Epidemiological studies to determine whether IgG4 prevalence correlates with breakthrough infections.
- Vaccine reformulation strategies to ensure sustained protective immunity without excessive immune tolerance.
The rise of IgG4 after repeated mRNA vaccination is a biological twist that demands serious attention.
The study shows that mRNA “vaccines” are training immune systems to tolerate diseases rather than eliminate them.
The findings should cause serious doubts over the future of mRNA-based immunology itself.
Yet, despite the growing concerns, globalists are still pushing vaccinations onto populations around the world.
Last month, members of the World Economic Forum (WEF) unveiled plans for permanently mass-vaccinating the general public “every six months” with “long-acting” mRNA “vaccines” as part of an alleged effort to supposedly tackle multiple diseases.
During panel discussions at last month’s annual WEF meeting in Davos, Switzerland, globalists laid out plans for tech-driven precision medicine, “long-acting injectables,” “climate-sensitive” vaccines, and mRNA therapeutics for non-communicable diseases.
No comments:
Post a Comment